European 100 Study Reveals: Despite Year-over-Year Improvements, Tremendous Opportunity to Enhance Hiring with AI, Automation and Experience Remains
Phenom released the second annual European Edition of its State of Candidate Experience Report, revealing significant improvement in the use of AI over one year and shining a spotlight on enormous opportunities for companies to enhance job seekers’ experiences through intelligence and automation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601005156/en/
‘State of Candidate Experience: 2023 Benchmarks Report — European Edition’ reveals, despite year-over-year improvements, tremendous opportunity to enhance hiring with AI, automation and experience remains. The second annual report provides recommendations, including small steps for making big impacts. (Photo: Business Wire)
Phenom audited the top 100 European companies of the Global 500 list in three key areas of the talent journey: attraction, engagement and conversion, as well as the use of AI. By viewing their strengths, weaknesses and opportunities for improvement, HR leaders, talent acquisition teams and hiring managers can gain valuable insights and best practices to improve the candidate experience, grow quality talent pools faster and hire more efficiently.
The 2023 audit of European 100 career sites reveals improvement year-over-year to deliver hyper-personalized experiences and job matching that strengthen candidate attraction, engagement and conversion, including a:
- 525% increase in presenting job recommendations based on browsing history
- 67% increase in using a recruitment chatbot
- 64% increase in showing job recommendations based on geographic location
- 60% increase in displaying recently viewed jobs
Although organizations are increasingly adopting AI-powered technology to improve experiences, 94% scored poorly in their use of AI, indicating there is still a significant gap between the solutions available and what companies have implemented. According to the 2023 audit:
- 90% did not use a recruitment chatbot
- 83% did not display recently viewed jobs
- 82% did not share job recommendations based on geographic location
- 75% did not present job recommendations based on browsing history
“Enhancing the candidate experience is a critical step in attracting the right qualified talent in this highly competitive market,” said Mahe Bayireddi, CEO and co-founder of Phenom. “Providing phenomenal, personalized experiences for job seekers is only possible through intelligence and automation.”
The ROI of Intelligence, Automation and Experience
Although retaining employees has become a primary goal for European companies, proactively improving the candidate experience remains an imperative. Organisations are struggling to fill open positions amidst economic challenges including an energy crisis, inflation and an ultra-competitive talent market.
To outpace competitors, employers must embrace cutting-edge practices and AI technology for hiring, developing and retaining talent. Intelligence, automation and experience are essential to overcoming today’s biggest talent acquisition and retention challenges, including simplifying the job search process and maintaining an attractive, unique employer brand. Hyper-personalized career sites, conversational chatbots, automated screening and scheduling, and content that showcases a company’s culture all enrich the candidate experience, helping them find the right job faster and apply.
Savvy organisations that are leveraging AI-powered technology and automation through the Phenom Intelligent Talent Experience platform are attracting more best-fit job seekers, growing talent communities and increasing completed applications, and the results speak for themselves:
- A major telecommunications company increased career site traffic by 220% and increased completed applications by 700% with intelligent tools that provided a more personalized experience for candidates
- A large health care organisation achieved a 10% increase in nursing hires by expediting communication with candidates through a conversational chatbot and SMS messages
- A leading financial institution added 8X more candidates to their talent community by creating a dynamic, hyper-personalized career site and targeting recruitment marketing efforts
- A popular restaurant chain registered over 12,000 candidates through their career site and talent email campaigns in less than a month — resulting in more than 2,000 same-day offers to candidates and 1,300+ same-week hires
Actions Organisations Can Take to Accelerate Hiring
To improve the candidate experience, Phenom’s European Edition of its State of Candidate Experience Report prescribes a series of actions organisations can take — from creating strong employer brand content to implementing intelligent technology on its career site:
- Personalize the candidate experience through AI and automation. Candidates today expect the online job search to be similar to purchasing consumer goods, where relevant information is delivered based on their interests. If this process isn’t intuitive and simple, they are more likely to drop off a career site. With AI and automation on a career site, personalized jobs and content automatically displayed for candidates based on their resume, experience, skills, and geographic location.
- Showcase a strong employer brand through content. When deciding if a job is the right fit for them, candidates spend a significant amount of time researching a company. If your digital brand doesn’t meet their expectations, they may not feel a strong connection and apply to an open role. Content on a career site (videos, pictures, blogs, etc.) that conveys information such as your company’s mission and purpose, overall workplace culture, employee quotes and stories, internal events and employee resource groups all paint a picture of what it’s like to work there.
- Embrace cutting-edge technology. In addition to AI and automation, organizations must be quick to adopt work-altering innovations, such as: generative AI — which enables organisations to reach previously unattainable levels of productivity and fill roles faster by automatically creating content, surfacing actionable intelligence, and eliminating time-consuming tasks; interview intelligence, which brings transparency to hiring teams through recordings, transcriptions, key takeaway, and analysis to move the process forward faster; and candidate hub, a one-stop-shop that helps candidates understand where they are in the hiring process and prepare for next steps.
With Phenom, candidates find and choose the right job faster, employees develop their skills and evolve, recruiters become wildly productive, managers build stronger-performing teams, HR aligns employee development with company goals, and HRIS easily integrates existing HR tech to create a holistic infrastructure.
To read the full State of Candidate Experience: 2023 Benchmarks Report — European Edition and company rankings, download here.
About Phenom
Phenom has a purpose of helping a billion people find the right job. Through AI-powered talent experiences, employers are using Phenom to hire employees faster, develop them to their full potential, and retain them longer. The Phenom Intelligent Talent Experience platform seamlessly connects candidates, employees, recruiters, hiring managers, HR and HRIS — empowering over 500 diverse and global enterprises with innovative products including Phenom Career Site, Chatbot, CMS, CRM, AI Scheduling, Video Assessments, Campaigns, University Recruiting, Talent Marketplace, Career Pathing, Gigs, Mentoring, and Referrals.
Phenom has earned accolades including: Inc. 5000’s fastest-growing companies (3 consecutive years), Deloitte Technology's Fast 500 (4 consecutive years), five Brandon Hall ‘Excellence in Technology’ awards including Gold for ‘Best Advance in AI for Business Impact,’ Business Intelligence Group's Artificial Intelligence Excellence Awards (3 consecutive years), and a regional Timmy Award for launching and optimizing HelpOneBillion.com (2020).
Headquartered in Greater Philadelphia, Phenom also has offices in India, Israel, the Netherlands, Germany and the United Kingdom.
For more information, please visit www.phenom.com. Connect with Phenom on LinkedIn, Twitter, Facebook, YouTube and Instagram.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230601005156/en/
Contact information
Media:
Jennifer Lyons
Director, Global Communications
267-379-5066
jennifer.lyons@phenompeople.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release
Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
